S. and 25 other countries.
One-fourth were black or Hispanic, and 40 percent were women. Men
were 50 or older; women, 60 or older. There was no past medical history of heart problems or diabetes.
They were randomly assigned to take a placebo (dummy pills) or Crestor, made by British-based AstraZeneca PLC.
The results were significant enough that the trial was halted early, only after 2 years because the evidence was strong enough to conside
r placing all participants on crestor.